Incyte Corp. (INCY)
127.99
+0.18
(+0.14%)
USD |
NASDAQ |
Aug 24, 16:00
127.99
0.00 (0.00%)
After-Hours: 20:00
Incyte Total Liabilities (Quarterly) : 1.528B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.528B |
| March 31, 2026 | 1.716B |
| December 31, 2025 | 1.803B |
| September 30, 2025 | 1.679B |
| June 30, 2025 | 1.650B |
| March 31, 2025 | 2.082B |
| December 31, 2024 | 2.035B |
| September 30, 2024 | 1.841B |
| June 30, 2024 | 1.665B |
| March 31, 2024 | 1.741B |
| December 31, 2023 | 1.632B |
| September 30, 2023 | 1.457B |
| June 30, 2023 | 1.468B |
| March 31, 2023 | 1.335B |
| December 31, 2022 | 1.513B |
| September 30, 2022 | 1.284B |
| June 30, 2022 | 1.234B |
| March 31, 2022 | 1.191B |
| December 31, 2021 | 1.204B |
| September 30, 2021 | 1.050B |
| June 30, 2021 | 968.76M |
| March 31, 2021 | 933.59M |
| December 31, 2020 | 972.49M |
| September 30, 2020 | 916.60M |
| June 30, 2020 | 867.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 814.70M |
| December 31, 2019 | 828.34M |
| September 30, 2019 | 792.29M |
| June 30, 2019 | 700.44M |
| March 31, 2019 | 668.59M |
| December 31, 2018 | 719.80M |
| September 30, 2018 | 717.05M |
| June 30, 2018 | 664.23M |
| March 31, 2018 | 677.97M |
| December 31, 2017 | 671.95M |
| September 30, 2017 | 616.55M |
| June 30, 2017 | 612.61M |
| March 31, 2017 | 641.41M |
| December 31, 2016 | 1.219B |
| September 30, 2016 | 1.174B |
| June 30, 2016 | 1.121B |
| March 31, 2016 | 876.19M |
| December 31, 2015 | 836.28M |
| September 30, 2015 | 843.20M |
| June 30, 2015 | 875.16M |
| March 31, 2015 | 904.04M |
| December 31, 2014 | 911.70M |
| September 30, 2014 | 874.86M |
| June 30, 2014 | 850.10M |
| March 31, 2014 | 829.25M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 1.055B |
| Regeneron Pharmaceuticals, Inc. | 10.02B |
| BioMarin Pharmaceutical, Inc. | 5.402B |
| Eli Lilly & Co. | 108.40B |
| Biogen, Inc. | 13.24B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.873B |
| Shareholders Equity (Quarterly) | 6.344B |
| Debt to Equity Ratio | 0.006 |
| Current Ratio | 4.593 |
| Net Debt Paydown Yield | 0.00% |